Skip to content

Safety and effectiveness of thirst granule intervention in prediabetes clinical research

Safety and effectiveness of thirst granule intervention in prediabetes clinical research - Type 2 diabetes TCM evidence-based ability improvement project

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090766
Enrollment
Unknown
Registered
2024-10-12
Start date
2023-07-13
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

control group:Lifestyle intervention
treatment group:On the basis of the control group, it were added by Tasly Pharmaceutical Group Co., LTD. Composition: know mother, atractylodes, Coptis chinensis, puhuang, ground brocade grass.

Sponsors

The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Prediabetes people who meet the diagnostic criteria of Western medicine (2) Age 20 ~70 years (including both ends), gender is not limited (3) The subject was informed and voluntarily signed the informed consent form (4) Those who are willing to obey the doctor's treatment plan and cooperate with the follow-up patient

Exclusion criteria

Exclusion criteria: (1) did not meet the diagnostic criteria and inclusion criteria (2) Acute cardiovascular and cerebrovascular events or myocardial infarction within 6 months (3) Patients with proliferative retinopathy requiring laser treatment (4) Stress state or secondary blood sugar rise (5) Not willing to cooperate (can not match the diet, exercise control, or do nottake drugs according to the regulations) (6) Mentally ill (7) Women who are pregnant or lactating, and women who are planning for pregnancy or have no contraceptive program (8) Those who may be allergic to the test drug (9) Age is 70 years old (10) Patients with other endocrine diseases or other serious primary diseases

Design outcomes

Primary

MeasureTime frame
fasting blood-glucose ;Blood glucose was obtained 2h after meal;

Secondary

MeasureTime frame
glycosylated hemoglobin ;Fasting insulin;TCM Syndrome Integral Scale;

Countries

China

Contacts

Public ContactFang Zhaohui

The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine

fangzhaohui9097@163.com+86 139 6505 9097

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026